Emphysema

Emphysema Symptoms

emphysema-symptoms

Emphysema Symptoms

Emphysema symptoms are not always immediately apparent. In fact, some people can have the condition for several years before they experience any noticeable discomfort. Typically, the first sign to appear is shortness of breath, which is usually mild at first and gradually intensifies over time. Most people seek treatment when their breathing difficulties cause them to avoid certain activities and interfere with their quality of life.

In addition to shortness of breath and a general feeling that they can’t get enough air, many people with emphysema experience additional symptoms such as:

  • Persistent coughing
  • Wheezing
  • Excessive mucus production
  • Chest pain or tightness
  • General fatigue
  • Loss of appetite
  • Depression

Traditionally, several approaches have been used to help relieve the symptoms of emphysema. Some patients benefit from the use of bronchodilators, inhaled steroids, antibiotics, pulmonary rehabilitation, nutrition therapy and/or supplemental oxygen. However, while these techniques can help with symptom control, they cannot address the underlying cause of emphysema within the lungs. To achieve this, lung volume reduction surgery or a lung transplant may be recommended, but usually only in very severe cases.

For patients who are looking for an alternative treatment for emphysema and its symptoms, the Lung Institute offers a promising option. Specifically, we use autologous cells derived from a patient’s own body to help promote healing within the lungs and potentially slow the progression of lung damage. The latter aspect is especially important because emphysema has no cure — it is a chronic condition that worsens over time.

If traditional forms of treatment for emphysema symptoms have not provided you with the relief you need, you may benefit from the Lung Institute’s groundbreaking alternative. To learn more about cellular therapy for chronic lung conditions, contact us at (800) 729-3065. Our innovative treatments are performed on an outpatient basis, and comprehensive follow-up care is provided by our caring medical team.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.